Skip to content
During the 2023 BIO International Convention, the Biotechnology Innovation Organization (BIO) released its seventh-annual best practices report, “The U.S. Biosciences Industry in the States: […]
How can states grow their biosciences sectors? Read More »
Partnership has been the key to developing and delivering many of today’s most important medicines to patients. From the rapid development of COVID-19 vaccines
The Inflation Reduction Act (IRA) will introduce arbitrary changes in drug development as pharma companies are forced to work with complex new regulations that
BIO panels break down IRA’s challenges for drug makers and patients Read More »
On June 8, a Food and Drug Administration (FDA) advisory committee voted unanimously in favor of recommending traditional approval for LEQEMBI, the Alzheimer’s drug
FDA advisory committee endorses LEQEMBI Read More »
Successful private efforts to share COVID-19 technology were highlighted at a June 7 conference, the day after a House hearing pointed out flaws in
Strong IP helped us share COVID technology, WTO waivers do harm, experts say Read More »
Healthcare on the African continent is changing. “At the current pace, the annual rate of cancer in Africa is projected to reach 1.4 million
How do we achieve the cancer moonshot in Africa? Read More »
Psychedelics have established themselves as a game changer in the drug development space in recent years. And it is not just scientists who are
Psychedelics ‘do things in the brain that nothing else does’ Read More »
Andrew Marshall’s life turned upside down when he was 16 and received an acute lymphoblastic leukemia diagnosis. As a budding musician, he would sit
The ultimate collaboration: Make-A-Wish Foundation and biotech Read More »
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation
How can we increase routine adult vaccination? Read More »
The disease burden of RSV has been a tough problem for biotech R&D to solve for over 60 years. However, within the last year,
We’re conquering RSV for the young and old – but more innovation is needed Read More »
